Filing Flows › Comparisons › COYA vs SCYX
Coya Therapeutics vs Scynexis: COYA and SCYX compared
Coya Therapeutics is the larger company: $244K of revenue in its latest quarter (Q2 2026) against $235K for Scynexis (Q2 2026). Coya Therapeutics is growing faster (+49% against -83% a year earlier).
Where the money goes: COYA and SCYX
Coya Therapeutics (COYA) · Q2 2026
Coya Therapeutics, Q2 2026: revenue $244K (+49% year over year), net loss $6.6M, operating cash flow −$7.4M. The chart follows the revenue to costs, profit and cash.
Scynexis (SCYX) · Q2 2026
Scynexis, Q2 2026: revenue $235K (-83% year over year), net earnings $7.4M, operating cash flow −$14.9M. The chart follows the revenue to costs, profit and cash.
| Coya Therapeutics (COYA) | Scynexis (SCYX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $244K | $235K |
| Revenue growth, Y/Y | +49% | -83% |
| Operating margin | n/m | n/m |
| Net earnings | −$6.6M | $7.4M |
| Operating cash flow | −$7.4M | −$14.9M |
| Market value | — | $45.0M |
| Analysts’ mean target | — | $36.33 |
Questions
Which is bigger, Coya Therapeutics or Scynexis?
Coya Therapeutics is the larger company: $244K of revenue in its latest quarter (Q2 2026) against $235K for Scynexis (Q2 2026).
Is Coya Therapeutics or Scynexis growing faster?
Coya Therapeutics is growing faster (+49% against -83% a year earlier).
More: Coya Therapeutics earnings · how Coya Therapeutics makes money · Scynexis earnings · how Scynexis makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.